Explore more price target data and ratings for Molina Healthcare Inc on the Forecasts tab, and track all previous and future analyst recommendations for Molina Healthcare Inc in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This in…
Q2 2026 saw strong Medicaid and Medicare duals performance, offset by Marketplace losses due to adverse member mix and risk adjustment items. Full-year EPS guidance was raised to at least $5.25, with 2026 as a trough year for Medicaid margins and optimism for 2027 margin recovery.Based on Molina He…
Q2 2026 net income fell to $60 million on lower membership and premium revenue, higher medical care ratio, and a $93 million impairment charge. Medicaid, Medicare, and Marketplace segments all saw margin declines, with challenging medical cost trends and regulatory changes expected to pressure futu…
Q2 2026 saw strong Medicaid and Medicare duals performance, offsetting Marketplace losses and MAPD exit. Full-year EPS guidance was raised to at least $5.25, with 2027 EPS building blocks exceeding $10 per share and long-term targets reaffirmed.Based on Molina Healthcare Inc [MOH] Q2 2026 Audio Tra…
Q2 2026 saw a sharp year-over-year decline in earnings and revenue, driven by lower membership and higher medical costs, but operating cash flow improved. Full year adjusted EPS guidance was raised to at least $5.25, with Medicaid and Medicare segments performing in line or better than expectations…
Molina Healthcare reported second-quarter 2026 results with total revenue of $10.874 billion, GAAP diluted EPS of $1.19 and adjusted diluted EPS of $1.51. The company served approximately 4.9 million members as of June 30, 2026 and raised full-year 2026 adjusted earnings guidance to at least $5.25…
